Avalo Therapeutics, Inc. (AVTX) stock
AVTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$6.70−0.43 (-6.03%)
Close on Nov 18, 2026Market cap $359.32MP/E –Yield –
Avalo Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Avalo Therapeutics's price to book ratio was 1.0× on Nov 11, 2026, against 3.7× a year earlier. Over the last 5 years it ranged from 0.3× to 13.8×, with a median of 3.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.0× | −2.5 |
| 2025 | Dec 31, 2025 | 3.5× | +0.1 |
| 2024 | Dec 31, 2024 | 3.4× | +2.9 |
| 2023 | Dec 29, 2023 | 0.5× | −4.8 |
| 2022 | Jul 29, 2022 | 5.3× | +0.6 |
| 2021 | Dec 31, 2021 | 4.7× | −0.4 |
| 2020 | Dec 31, 2020 | 5.1× | −7.9 |
| 2019 | Dec 31, 2019 | 13.0× | +6.3 |
| 2018 | Dec 31, 2018 | 6.7× | +3.0 |
| 2017 | Dec 29, 2017 | 3.8× | −9.8 |
| 2016 | Dec 30, 2016 | 13.6× | – |
See a number that looks wrong?